Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Humanised monoclonal antibody against myostatin

EU orphan designation number: EU/3/13/1105   
Active ingredient: Humanised monoclonal antibody against myostatin
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2013 Orphan designation EMA/OD/164/12 (2013)806 of 08/02/2013